Effect of portal vein embolization on function of the nonembolized lobes of the liver: Evaluation by first-pass hepatic lidocaine extraction in dogs

Surgery

Volumn 132, Issue 3, 2002, Pages 424-430

  Tominaga, Masahiro ^a   Ku, Yonson ^a   Iwasaki, Takeshi ^a   Fukumoto, Takumi ^a   Muramatsu, Sanshiro ^a   Kusunoki, Nobuya ^a   Suzuki, Yasuyuki ^a   Fujino, Yasuhiro ^a   Kuroda, Yoshikazu ^a  

^a KOBE UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHARCOAL; LIDOCAINE;

ANIMAL EXPERIMENT; ARTICLE; ARTIFICIAL EMBOLISM; CORRELATION ANALYSIS; DOG; DRUG BLOOD LEVEL; DRUG INFUSION; FEMALE; FILTER; FIRST PASS EFFECT; HEMOPERFUSION; LIVER FUNCTION TEST; LIVER PARENCHYMA; LIVER RESECTION; LIVER WEIGHT; MALE; NONHUMAN; PORTAL VEIN; PRIORITY JOURNAL;

EID: 0036748098     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-6060(02)00107-1     Document Type: Article

References (30)

1. Makuuchi M, Thai BL, Takayasu K, Takayama T, Kosuge T, Gunven P, et al. Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma: a preliminary report. Surgery 1990;107:521-7.
2. Imamura H, Shimada R, Kubota M, Matsuyama Y, Nakayama A, Miyagawa S, et al. Preoperative portal vein embolization. An audit of 84 patients. Hepatology 1999;29:1099-105.
3. Kawasaki S, Makuuchi M, Miyagawa S, Kakazu T. Radical operation after portal embolization for tumor of hilar bile duct. J Am Coll Surg 1994;178:480-6.
4. Kinoshita H, Sakai K, Hirohashi K, Igawa S, Yamasaki O, Kubo S. Preoperative portal embolization for hepatocellular carcinoma. World J Surg 1986;10:803-8.
5. Nagino M, Nimura Y, Kamiya J, Kondo S, Uesaka K, Kin Y, et al. Changes in hepatic lobe volume in biliary tract cancer patients after right portal vein embolization. Hepatology 1995;21:434-9.
6. Yamakado K, Takeda K, Matsumura K, Nakatsuka A, Hirano T, Kato N, et al. Regeneration of the un-embolized liver parenchyma following portal vein embolization. J Hepatol 1997;27:871-80.
7. Rous P, Larimore LD. Relation of the portal blood to liver maintenance. A demonstration of liver atrophy conditional on compensation. J Exp Med 1920;31:609-32.
8. Uesaka K, Nimura Y, Nagino M. Changes in hepatic lobar function after right portal vein embolization. An appraisal by biliary indocyanine green excretion. Ann Surg 1996;223:214-20.
9. Otsuki K, Asano T, Okazumi S, Enomoto K, Ishiwata K, Takayama W, et al. Assessment of residual liver functional reserve after portal embolization with positron emission tomography using L-(methyl-11C) methionine and computed tomography. J Hepatobiliary Pancreat Surg 1997;4:377-83.
10. Thomson PD, Melmon KL, Richardson JA, Cohn K, Steinbrunn W, Cudihee R, et al. Lidocaine pharmacokinetics in advanced heart failure, liver disease, and renal failure in humans. Ann Intern Med 1973;78:499-508.
11. Williams RL, Mamelok RD. Hepatic disease and drug pharmacokinetics. Clin Pharmacokinet 1980;5:528-47.
12. Chandel B, Shapiro MJ, Kurtz M, Rana WZ, Matthews M, Jellinck M, et al. MEGX (monoethylglycinexlidide): a novel in vivo test to measure early hepatic dysfunction after hypovolemic shock. Schock 1995;3:51-3.
13. Schroeder TJ, Gremse DA, Mansour ME, Theuerling AW, Brunson ME, Ryckman FC, et al. Lidocaine metabolite formation as an index of liver function in hepatic transplant donors and recipients. Transplant Proc 1989;21:2299-301.
14. Shiffman ML, Fisher RA, Sanyal AJ, Edinboro LE, Luketic VA, Purdum PP, et al. Hepatic lidocaine metabolism and complications of cirrhosis. Implications for assessing patient priority for hepatic transplantation. Transplantation 1992;55:830-5.
15. Gremse DA, A-Kader HH, Schroeder TJ, Balistreri WF. Assessment of lidocaine metabolite formation as a quantitative liver function test in children. Hepatology 1990;12:565-9.
16. Ku Y, Saitoh M, Nishiyama H, Fujiwara S, Iwasaki T, Tominaga M, et al. Extracorporeal removal of anticancer drugs in hepatic artery infusion: the effect of direct hemoperfusion combined with venovenous bypass. Surgery 1990;107:273-81.
17. Iwasaki T, Ku Y, Kusunoki N, Tominaga M, Fukumoto T, Muramatsu S, et al. Regional pharmacokinetics of doxorubicin following hepatic arterial and portal venous administration: evaluation with hepatic venous isolation and charcoal hemoperfusion. Cancer Res 1998;58:3339-43.
18. Ku Y, Fukumoto T, Tominaga M, Iwasaki T, Maeda I, Kusunoki N, et al. Single catheter technique of hepatic venous isolation and extracorporeal charcoal hemoperfusion for malignant liver tumors. Am J Surg 1997;173:103-9.
19. Ku Y, Iwasaki T, Fukumoto T, Tominaga M, Muramatsu S, Kusunoki N, et al. Induction of long-term remission in advanced hepatocellular carcinoma with percutaneous isolated liver chemoperfusion. Ann Surg 1998;227:519-26.
20. Jolley ME, Stroupe SD, Wang CHJ, Panas HN, Keegan CL, Schmidt RL, et al. Fluorescence polarization immunoassay. Monitoring aminoglycoside antibiotics in serum and plasma. Clin Chem 1981;27:1190-7.
21. Oellerich M, Raude E, Burdelski M, Schulz M, Schmidt FW, Ringe B, et al. Monoethylglycinexylidide formation kinetics. A novel approach to assessment of liver function. J Clin Chem Clin Biochem 1987;25:845-53.
22. Okamoto E, Kyo A, Yamanaka N, Tanaka N, Kuwata K. Prediction of the safe limits of hepatectomy by combined volumetric and functional measurements in patients with impaired hepatic function. Surgery 1984;95:586-92.
23. Matsumata T, Kanematsu T, Yoshida Y, Furuta T, Yanaga K, Sugimachi K. The indocyanine green test enables prediction of postoperative complications after hepatic resection. World J Surg 1987;11:678-81.
24. Stenson RE, Constantino RT, Harrison DC. Interrelationship of hepatic blood flow, cardiac output, and blood levels of lidocaine in man. Circulation 1971;43:205-11.
25. Rowland M, Thomson PD, Guichard A, Melmon KL. Disposition kinetics of lidocaine in normal subjects. Ann NY Acad Sci 1971;179:383-98.
26. Gianelly R, Von der Groeben JO, Spivack AP, Harrison DC. Effect of lidocaine on ventricular arrhythmias in patients with coronary heart disease. N Engl J Med 1967;277:1215-9.
27. Jewitt DE, Kishon Y, Thomas M. Lidocaine in the management of arrhythmias after acute myocardial infarction. Lancet 1968;1:266-70.
28. Shiffman ML, Luketic VA, Sanyal AJ, Duckworth PF, Purdum PP, Contos MJ, et al. Hepatic lidocaine metabolism andliver histology in patients with chronic hepatitis and cirrhosis. Hepatology 1994;19:933-40.
29. Guengerich FP. Characterization of human microsomal cytochrome P-450 enzymes. Annu Rev Pharmacol Toxicol 1989;29:241-64.
30. De Baere T, Roche A, Elias D, Lasser P, Lagrange C, Bousson V. Preoperative portal vein embolization for extension of hepatectomy indications. Hepatology 1996;24:1386-91.